William See
Physician · Sanford Medical Center Fargo
Credentials: · · ·
History
Research
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
European Urology · 2015 · 538 citations
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
BJU international · 2006 · 198 citations
The Journal of Urology · 2002 · First of 18 authors · 171 citations
17 papers · 1 as a fellow
16 papers
12 papers
10 papers
8 papers
8 papers
7 papers
5 papers
Grants
- 2014–2018
BCG-Induced Oxidative Stress as a Target for Improved Clinical Efficacy
Department of Veterans Affairs · I01
Contact PI · Clement j. Zablocki Va Medical Center
- 1995–2002
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $1.6M · University of Iowa
- 1997–2000
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $82.4K · University of Iowa
Clinical trials
- 1995–2008
Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Principal investigator · Completed · Phase 3
AstraZeneca